TORONTO, Dec. 17, 2012 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and
manufacturing services to the global pharmaceutical industry, today
announced, in connection with the close of the Banner acquisition, that
Geoff Glass has been appointed president of the new proprietary
products business unit.
"Geoff has played an integral role on Patheon's leadership team, and I
continue to be impressed with his focus on exceeding expectations and
driving results. This is an exciting time for Patheon and I am
confident in Geoff's ability and expertise to be able to progress this
new business unit forward," stated James C. Mullen, Patheon's Chief
Mr. Glass has been with Patheon for approximately four years, overseeing
sales and marketing initiatives worldwide as Executive Vice President,
Global Sales and Marketing. He has over 17 years of experience in the
About Patheon Inc.
Patheon Inc. (TSX: PTI) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical
industry. The company provides the highest quality products and
services to approximately 300 of the world's leading pharmaceutical and
biotechnology companies. Patheon's services range from preclinical
development through commercial manufacturing of a full array of solid
and sterile dosage forms.
The company's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization.
The company's integrated development and manufacturing network of nine
manufacturing facilities and nine development centers across North
America and Europe, enables customer products to be launched with
confidence anywhere in the world. For more information visit www.Patheon.com.
SOURCE Patheon Inc.